Kenneth Remy, the Ellery Sedgwick, Jr. Chair and Distinguished Scientist in Cardiovascular Research and inaugural director of the Blood, Heart, Lung, and Immunology Research Center at Case Western Reserve University and University Hospitals of Cleveland, was recently elected chair of the Research Section for the Society of Critical Care Medicine.
Remy also is a faculty member in the Departments of Internal Medicine and Pediatrics.
The Society of Critical Care Medicine (SCCM) is the largest nonprofit medical organization in the practice of critical care. SCCM was established in 1970 and is an independently incorporated international, educational and scientific society based in the United States. Its members are multi-professional health professionals providing care to critically ill and injured patients, and SCCM is the only organization representing all critical care team’s professional components. The society supports research and education and advocates on issues related to critical care. The society has over 35,000 members worldwide, and the research section has over 4,000 section members. A central component of the society’s mission is the support of quality-based improvement initiatives and the support of multi-professional research at all levels. The Research Section supports research development among society members and promotes communication about opportunities and networks.
Remy also serves as University Hospitals Rainbow Babies & Children’s Hospital first international expert for the Surviving Sepsis Campaign (SSC) of the International Surviving Sepsis Campaign. This campaign is a joint initiative of the SCCM and the European Society of Intensive Care Medicine (ESICM). The SSC is a team of multidisciplinary, international experts committed to improving the time to recognize and treat sepsis and septic shock.
Remy is an international expert in adult and pediatric sepsis, COVID-19 disease, and global health. As an adult and pediatric critical care physician, his research focuses on heme-based trafficking and signaling in immune dysregulation in the context of diseases of intravascular hemolysis (COVID, sepsis, malaria, sickle cell disease, thalassemia) and after red blood cell transfusion, and real-time immunophenotyping of pro and hypoinflammatory states to identify timing for immunoadjuvant therapies.
In this new role as chair, Remy endeavors to grow multidisciplinary research across methodologies (implementation science, data science, basic and translational science, bereavement and palliative care, simulation, and education research, global health research, and mixed methods work) to further expand the ability to learn new associations and develop causal pathways in critical illness.